Three EU Biosimilar Approvals In Five Months? Aurobindo Thinks So

Aurobindo’s CuraTeQ Biologics Arm Bags Key EU Manufacturing Certification

Aurobindo is looking to finally put a key manufacturing disruption behind it in Europe, enabling the firm to gain traction for some of its early biosimilar filings.

GMP logo
(Shutterstock)

More from Manufacturing

More from Generics Bulletin